Table 3.
Results on HLA-DRB1*0101 and HLA-DRB1*0301
| Allele | Method | Acc. | AROC | AROC50 | MCC | AOVER-ROC |
| HLA-DRB1*0101 | SKM (β = 0.04) | 0.886 | 0.912 | 0.804 | 0.643 | 0.088 |
| SKM (β = 0.085) | 0.901 | 0.904 | 0.778 | 0.690 | 0.096 | |
| LP_top2 | 0.779 | 0.221 | ||||
| TEPITOPE | 0.842 | 0.158 | ||||
| HLA-DRB1*0301 | SKM (β = 0.06) | 0.763 | 0.823 | 0.580 | 0.531 | 0.177 |
| SKM (β = 0.08) | 0.757 | 0.827 | 0.575 | 0.525 | 0.173 | |
| LP_top2 | 0.721 | 0.279 | ||||
| TEPITOPE | 0.585 | 0.415 | ||||
Results of 5-fold cross-validation with best results shown in bold. Results from LP_top2 and TEPITOPE are taken from [21]. Measurements are same as previously reported, except for AOVER-ROC, which is the area over the ROC curve. AROC = 1.00 is perfect classification, so AOVER-ROC, 1- AROC, can be seen as an error measure.